Advertisement

Picture [iito] Männer Ballett 650x80px

News > All

Total search results: 1614 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
[iito] Business Intelligence. (7/15/20). "Press Release: [iito] Launches ADucation Campaign Summer 2020". Bremen. 2020-07-15
Reapplix A/S. (7/14/20). "Press Release: Reapplix Receives New Reimbursement Coding and Completes USD 22.6m Equity Financing to Drive US Commercialization". 2020-07-14
Eir Ventures. (7/10/20). "Press Release: New Nordic Life Science Venture Fund, Eir Ventures, Launched to Leverage the Untapped Potential of Health Care Innovation". Stockholm & Copenhagen. 2020-07-10
Novo Holdings A/S. (7/9/20). "Press Release: Major Danish Contribution to Billion-dollar Global Initiative to Combat Antimicrobial resistance". Copenhagen. 2020-07-09
VarmX B.V.. (7/8/20). "Press Release: VarmX Raises €32 million in Series B Financing to Develop Innovative Reversal Agent for the Treatment and Prevention of Severe Bleeding in Patients on Oral Anticoagulants". Leiden. 2020-07-08
Kaiku Health. (7/8/20). "Press Release: Kaiku Health Expands Collaboration with Roche in Digital Patient Monitoring and Management". 2020-07-08
Gesynta Pharma AB. (7/7/20). "Press Release: Gesynta Raises SEK 190 Million in Round Led by Hadean Ventures to Accelerate Development of First-in-class mPGES-1 Inhibitor GS-248 for Systemic Sclerosis". Stockholm. 2020-07-07
Resistell AG. (7/3/20). "Press Release: Resistell AG Receives €2.5m EIC Accelerator Grant and Equity Financing Offer from EIC". 2020-07-03
Freeline Therapeutics Ltd.. (6/30/20). "Press Release: Freeline Closes $120 Million Series C Financing Round". London. 2020-06-30
Bavarian Nordic A/S. (6/12/20). "Press Release: Bavarian Nordic to Manufacture Additional Ebola Vaccines for Janssen". Copenhagen. 2020-06-12
Oncoinvent AS. (6/11/20). "Press Release: Oncoinvent Announces Dosing of First Patient with Radspherin in a Second Phase 1 Clinical Trial". Oslo. 2020-06-11
Novo Nordisk A/S. (6/11/20). "Press Release: Novo Nordisk to Acquire Corvidia Therapeutics and Expand Presence in Cardiovascular Disease". Bagsvaerd. 2020-06-11
Bioqube Ventures. (6/10/20). "Press Release: Bioqube Ventures Launches Bioqube Factory Fund I". Hasselt/Brussels. 2020-06-10
Genmab A/S. (6/10/20). "Press Release: Genmab and AbbVie Announce Broad Oncology Collaboration". Copenhagen & North Chicago, IL. 2020-06-10
Valo Therapeutics Ltd.. (6/8/20). "Press Release: Valo Therapeutics Announces Board Appointment of Dr Mai-Britt Zocca". Oxford & Helsinki. 2020-06-08
Boehringer Ingelheim. (6/8/20). "Press Release: New Consortium EUbOPEN Will Provide Tools to Unlock Disease Biology. 66 Million Euros to Generate Open-access Chemical Tools". Frankfurt & Ingelheim. 2020-06-08
Calliditas Therapeutics AB. (6/5/20). "Press Release: Calliditas Therapeutics Prices Its Initial Public Offering on The Nasdaq Global Select Market in the United States". 2020-06-05
Immatics Biotechnologies GmbH. (6/4/20). "Press Release: Immatics Appoints Cedrik Britten as Chief Medical Officer". Houston, TX & Tübingen. 2020-06-04
Novo Holdings A/S. (6/3/20). "Press Release: Novo Ventures Leads US$55m Series B Investment in NodThera". Copenhagen. 2020-06-03
Albumedix Ltd.. (6/1/20). "Press Release: Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial Officer". 2020-06-01
Rentschler Biopharma SE. (5/27/20). "Press Release: Rentschler Biopharma Extends Collaboration with Genmab to U.S. Facility". Laupheim & Milford, MA. 2020-05-27
Exscientia Ltd.. (5/26/20). "Press Release: Exscientia Raises $60 Million in Series C Financing Round Led by Novo Holdings". Oxford, Copenhagen & Hamburg. 2020-05-26
Albumedix Ltd.. (5/26/20). "Press Release: Albumedix Announces Jonas Skjødt Møller as New Chief Executive Officer". 2020-05-26
Cyxone AB. (5/20/20). "Press Release: Dr Tara Heitner Appointed New CEO for Cyxone". 2020-05-20
Elekta. (5/19/20). "Press Release: Acquisition of Kaiku Health Strengthens Elekta Digital Offering with Personalized Digital Health Interventions". Stockholm. 2020-05-19
Roche. (5/15/20). "Press Release: Roche Launches New Blood Gas Digital Solution Designed to Improve Patient Care". Basel. 2020-05-15
Calliditas Therapeutics AB. (5/14/20). "Press Release: Calliditas Publicly Files Registration Statement with SEC for a Proposed Initial Public Offering in the United States". 2020-05-14
Innovative Medicines Initiative (IMI). (5/12/20). "Press Release: IMI Announces COVID Projects, Boosts Funding Pot to EUR 72 million". Brussels. 2020-05-12
Aqilion AB. (5/11/20). "Press Release: Torgeir Vaage Joins Aqilion as Chief Financial Officer". Helsingborg. 2020-05-11
Ascendis Pharma A/S. (5/11/20). "Press Release: Ascendis Pharma A/S Will Appoint Jesper Høiland as Global Chief Commercial Officer". Copenhagen. 2020-05-11
Fluidigm Corporation. (5/7/20). "Press Release: Fluidigm Announces First Quarter 2020 Financial Results". South San Francisco, CA. 2020-05-07
Oncopeptides AB. (5/6/20). "Press Release: Oncopeptides Has Completed a Directed Share Issue Raising approximately SEK 1,414 Million (USD 144 M) [NOT FOR US, AU, CA, et al.]". Boston, MA. 2020-05-06
[iito] Business Intelligence. (5/4/20). "Press Release: [iito] Brings Back the Past into the [LSE] Newsletter". Bremen. 2020-05-04
Biograil ApS. (4/30/20). "Press Release: Biograil Announces Sanner Ventures Has Joined Investor Syndicate". Copenhagen. 2020-04-30
EnginZyme AB. (4/22/20). "Press Release: EnginZyme Secures €6.4 Million Series A Financing Round Led by Sofinnova Partners". Stockholm. 2020-04-22
Avectas Ltd.. (4/16/20). "Press Release: Avectas Completes Significant Series C Funding Bringing Total Invested Equity to Over $40 Million". Dublin. 2020-04-16
Leo Pharma A/S. (4/15/20). "Press Release: Leo Pharma Enters License Agreement with Oneness Biotech and Microbio Shanghai for FB825 a Novel Atopic Dermatitis and Asthma Drug Candidate". Ballerup. 2020-04-15
Neuro Event Labs Oy. (4/8/20). "Press Release: Neuro Event Labs Closes €3.9M Series A Round to Become the Standard for Epilepsy Diagnostics". 2020-04-08
Symphogen A/S. (4/3/20). "Press Release: Servier Signed a Definitive Agreement to Acquire Symphogen, a Leading Antibody Discovery Company, to Boost Its Antibody Capabilities and Leverage Its R&D Pipeline". Paris & Copenhagen. 2020-04-03
Apeiron Biologics AG. (4/2/20). "Press Release: Apeiron Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19". Vienna. 2020-04-02
Gilde Healthcare Partners. (3/31/20). "Press Release: Gilde Healthcare Raises €416 million ($450 million) Venture and Growth Capital Fund". Utrecht & Cambridge, MA. 2020-03-31
H. Lundbeck A/S. (3/27/20). "Press Release: Lundbeck Announces Phase IIa Study Results of Lu AG06466 in Adults with Tourette Syndrome". Valby. 2020-03-27
Biocat. (3/27/20). "Press Release: Barcelona to Host BIO-Europe Spring 2021". Barcelona. 2020-03-27
H. Lundbeck A/S. (3/27/20). "Press Release: Lundbeck Reports Headline Results from Phase IIa AMBLED study of Foliglurax in Parkinson’s Disease". Valby. 2020-03-27
Oxford Biomedica plc. (3/18/20). "Press Release: Building the Group for Future Growth. Business Update". Oxford. 2020-03-18
ImCheck Therapeutics S.A.S.. (3/17/20). "Press Release: ImCheck Therapeutics Expands Leadership Team with Appointment of Hans Henrik Chrois Christensen as Chief Financial Officer and Chief Operating Officer". Marseille. 2020-03-17
Tempus Labs, Inc.. (3/13/20). "Press Release: Tempus Announces $100 Million in Series G Financing". 2020-03-13
Lysogene S.A.. (3/12/20). "Press Release: Lysogene Completes €7.7 Million Capital Increase in a Placement Led by Leading Healthcare Investor OrbiMed and Lysogene Shareholder and Partner Sarepta [Not for US, CA, AU or JP]". Paris. 2020-03-12
Life Sciences Partners (LSP). (3/10/20). "Press Release: LSP Closes Largest Ever European Life Sciences Fund at $600 Million". Amsterdam, Munich & Boston, MA. 2020-03-10
Alligator Bioscience AB. (3/5/20). "Press Release: Alligator Bioscience Appoints Andreas Johannesson as Interim Chief Financial Officer". Lund. 2020-03-05
Agilent Technologies Inc.. (3/2/20). "Press Release: Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions". Santa Clara, CA & Copenhagen. 2020-03-02
Fluidigm Corporation. (2/26/20). "Press Release: Fluidigm Completes Acquisition of InstruNor AS". South San Francisco, CA. 2020-02-26
Genedata AG. (2/26/20). "Press Release: Leading Biopharma Experts Drive R&D Innovation and Process Efficiency at the Genedata Partner Symposium". Basel. 2020-02-26
FinnGen. (2/25/20). "Press Release: FinnGen Welcomes Janssen and Maze Therapeutics". 2020-02-25
DSM N.V.. (2/21/20). "Press Release: DSM to Acquire Glycom to Accelerate Growth in Early Life Nutrition". Heerlen. 2020-02-21
Optibrium Ltd.. (2/17/20). "Press Release: Optibrium Appoints Dr Tim Hohm as Director of Commercial Strategy and Business Development". Cambridge. 2020-02-17
Alligator Bioscience AB. (2/12/20). "Press Release: Alligator Bioscience AB Year-end Report January-December 2019". 2020-02-12
Nanoform Finland Ltd.. (2/10/20). "Press Release: Nanoform Establishes US Subsidiary". Helsinki. 2020-02-10
Orphazyme A/S. (2/7/20). "Press Release: Orphazyme Completes Offering of 7,032,937 Shares in a Directed Issue and Private Placement and Raises approximately DKK 745,000,000 (EUR 100 Million / USD 110 Million) [Not for US, CA, JP or AU]". Copenhagen. 2020-02-07
CureVac AG. (1/31/20). "Press Release: CureVac and CEPI Extend Their Cooperation to Develop a Vaccine against Coronavirus nCoV-2019". Tübingen & Boston, MA & Oslo. 2020-01-31
Orion Corporation. (1/31/20). "Press Release: Positive CHMP Opinion for Darolutamide as a New Treatment for Men with Non-metastatic Castration-resistant Prostate Cancer". 2020-01-31
GeNeuro S.A.. (1/31/20). "Press Release: GeNeuro Announces Successful €17.5 Million Private Placement [Not for United States, Australia, Canada, Japan, South Africa or any other Jurisdiction where Unlawful]". Geneva. 2020-01-31
Saga Diagnostics AB. (1/28/20). "Press Release: Saga Diagnostics Extends Its Collaboration with Servier to Use Ultrasensitive SAGAsafe Technology in Cancer Clinical Trials". Lund. 2020-01-28
Orion Corporation. (1/23/20). "Press Release: Marketing Authorization Granted for Darolutamide in Japan". 2020-01-23
Elypta AB. (1/23/20). "Press Release: Elypta Raises €6.1 Million in a Late Seed Round Led by Industrifonden". 2020-01-23
Blueprint Genetics Oy. (1/22/20). "Press Release: Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases". 2020-01-22
Coulter Partners. (1/21/20). "Press Release: Coulter Partners Secures Head of US Sales for Nanoform". 2020-01-21
Qlucore AB. (1/21/20). "Press Release: Qlucore Moves into New Business Areas and Expands Board". 2020-01-21
Novo Holdings A/S. (1/21/20). "Press Release: Novo Seeds Portfolio Company HepaRegeniX GmbH Secures Series B Financing in Excess of EUR 11 Million". Copenhagen. 2020-01-21
HepaRegenix GmbH. (1/21/20). "Press Release: HepaRegenix GmbH Secures Series B Financing in Excess of €11 Mio. to Advance First Drug Candidate to the Clinic". Tübingen. 2020-01-21
High-Tech Gründerfonds Management GmbH. (1/15/20). "Press Release: Biograil Secures Seed Funding for Oral Delivery Device with Potential to Transform Market for Injectables". 2020-01-15
Vivoryon Therapeutics AG. (1/14/20). "Press Release: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration". Halle (Saale) & Herlev. 2020-01-14
Nanoform Finland Ltd.. (1/13/20). "Press Release: Nanoform Appoints Head of US Sales". Helsinki. 2020-01-13
Valneva S.E.. (1/9/20). "Press Release: Valneva Expands its Commercial Operations with the Opening of its French Commercial Office". Saint-Herblain. 2020-01-09
NorthSea Therapeutics B.V.. (1/8/20). "Press Release: NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA Study in NASH and to Advance Two Additional SEFAs into the Clinic". Naarden. 2020-01-08
VectivBio AG. (1/7/20). "Press Release: VectivBio Launches with $35M Financing to Bring Best-in-Disease Medicines to Patients with Serious Rare Diseases". Basel. 2020-01-07
Novo Holdings A/S. (1/6/20). "Press Release: Novo Holdings REPAIR Impact Fund Invests USD 12 Million in Mutabilis and IBT Vaccines and Provides Strategic Update". Copenhagen. 2020-01-06
Savara Inc.. (12/20/19). "Press Release: Savara Announces Private Placement of $26.8 Million, With Total Potential Proceeds of $75.0 Million". Austin, TX. 2019-12-20
Bone Therapeutics S.A.. (12/19/19). "Press Release: Bone Therapeutics Announces the Appointment of Dr. Miguel Forte as CEO to Lead the Company into the Next Phase of Development". Gosselies. 2019-12-19
Genmab A/S. (12/19/19). "Press Release: Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics". Copenhagen & Tübingen. 2019-12-19
Zelluna Immunotherapy AS. (12/19/19). "Press Release: Zelluna Immunotherapy Appoints Namir Hassan as Chief Executive Officer". Oslo. 2019-12-19
BC Platforms. (12/18/19). "Press Release: BC Platforms Closes $15 Million Series C Financing and Signs Partnership with Iqvia to Extend Data Analytics in Genomics". Zürich & Boston, MA. 2019-12-18
Genomill Health. (12/18/19). "Press Release: Genomill Health Closes Investment Round to Expand Beta-testing with Liquid Biopsy Players". Turku. 2019-12-18
Alligator Bioscience AB. (12/17/19). "Press Release: First Patient Dosed with ATOR-1017 Developed for Metastasized Cancer". Lund. 2019-12-17
Sidekick Health. (12/16/19). "Press Release: Sidekick Partners with Bayer to Provide Digital Therapy Expansion for PAD Patients". 2019-12-16
Genmab A/S. (12/13/19). "Press Release: CHMP Issues Positive Opinion Recommending Darzalex (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma". Copenhagen. 2019-12-13
Immunicum AB. (12/13/19). "Press Release: Immunicum AB (publ) Announces Resignation of Carlos de Sousa as CEO". 2019-12-13
Alligator Bioscience AB. (12/11/19). "Press Release: CFO Per-Olof Schrewelius Leaves Alligator Bioscience". Lund. 2019-12-11
Owlstone Medical Ltd.. (12/10/19). "Press Release: Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure". Cambridge. 2019-12-10
BC Platforms. (12/6/19). "Press Release: BC Platforms Partners with Leading European Genomics Service Provider Center Life & Brain to Expand Genotyping Services Across Europe". Zürich & Boston, MA. 2019-12-06
Ferring Pharmaceuticals S.A.. (12/5/19). "Press Release: FerGene Announces Pivotal Phase 3 Study of Nadofaragene Firadenovec Met Its Primary Endpoint". Washington, DC. 2019-12-05
Unibio International plc. (12/4/19). "Press Release: Mitsubishi Corporation Invests in, and Partners with, Unibio". London & Copenhagen. 2019-12-04
BRAIN AG. (12/2/19). "Press Release: New Chairman of the Management Board – Adriaan Moelker Takes Over from Dr Jürgen Eck". Zwingenberg. 2019-12-02
Oncopeptides AB. (12/2/19). "Press Release: Oncopeptides Appoints Joseph Horvat as President North America". Stockholm. 2019-12-02
Alligator Bioscience AB. (11/29/19). "Press Release: Alligator Bioscience AB Appoints Chief Operating Officer". Lund. 2019-11-29
European Invesmtent Bank (EIB). (11/29/19). "Press Release: A European Fund to Support the Circular Bioeconomy". 2019-11-29
Avantium N.V.. (11/28/19). "Press Release: Avantium Secures Financing Milestone with €25 million EU Funding for FDCA Flagship Plant". Amsterdam. 2019-11-28
Novo Holdings A/S. (11/26/19). "Press Release: Novo Seeds Expands Company Formation Activities at BiOrigin with Seasoned Entrepreneurs". Copenhagen. 2019-11-26
Ferring Pharmaceuticals S.A.. (11/25/19). "Press Release: Ferring and Blackstone Life Sciences Invest over $570 Million USD in Novel Gene Therapy for Bladder Cancer Patients". Saint-Prex & Cambridge, MA. 2019-11-25
Asahi Kasei Corporation. (11/25/19). "Press Release: Presentation – Accelerating Transformation into a Global Health Care Company. Acquisition of U.S.-based Veloxis Pharmaceuticals Inc.". Tokyo. 2019-11-25
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page



Advertisement

Picture [iito] No Tracking 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top